JENNIFER SMITH: Open Payments
NPI 1811620370 · DONIPHAN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 27 payments from 17 companies in 2025. Trend: 2023 $115 · 2024 $375 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Grifols USA, LLC | 3 | $52 |
| PFIZER INC. | 3 | $44 |
| Novo Nordisk Inc | 2 | $35 |
| Exact Sciences Corporation | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Viatris Specialty LLC | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| ABBVIE INC. | 1 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
Products named: REXULTI, Prolastin-C Liquid, NURTEC ODT, Cologuard Collection Kit, TRELEGY ELLIPTA, YUPELRI, AIRSUPRA, EPKINLY.
Industry payments across MO — which companies pay providers there.
